Synthesis and antimicrobial activity of an SO 2 -releasing siderophore conjugate

A novel Trojan Horse conjugate consisting of an SO -releasing 2,4-dinitrobenzenesulfonamide group attached to the monocatecholate siderophore aminochelin was synthesized to examine whether a bidentate catecholate siderophore unit could help potentiate the antimicrobial activity of SO -releasing prodrugs. The conjugate obtained displays rapid SO release on reaction with glutathione, and proved more active against Staphylococcus aureus than a comparable SO -releasing prodrug lacking the siderophore unit, although activity required micromolar concentrations. The conjugate was inactive against wild-type Escherichia coli, but activity was observed against an entA mutant strain that is unable to produce its major siderophores. Hence, the poor activity of the conjugate in wild-type E. coli may be due to the production of native siderophores that can compete with the conjugate for iron binding and uptake.